CLINICAL_TRIALS
trial_result
· 2023-05-09
Clinical Trial Update: Study to Investigate the Effect of Hypoestes Rosea Powder in Parkinson's Disease [Phase 1, Phase 2]
Summary
A Phase 1/2 clinical trial evaluating Hypoestes Rosea Powder in Parkinson's disease has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Ibadan | Conditions: Parkinson Disease | Phase 1, Phase 2 | Status: COMPLETED